本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

10.08
-0.2100-2.04%
盤後:10.150.0700+0.69%19:53 EST
成交量:111.48萬
成交額:1,138.10萬
市值:6.16億
市盈率:-6.33
高:10.54
開:10.11
低:10.05
收:10.29
52周最高:35.34
52周最低:10.05
股本:6,113.68萬
流通股本:4,991.39萬
量比:1.44
換手率:2.23%
股息:- -
股息率:- -
每股收益(TTM):-1.5922
每股收益(LYR):-1.8336
淨資產收益率:-10.58%
總資產收益率:-8.69%
市淨率:0.68
市盈率(LYR):-5.50

資料載入中...

2026/11/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/05

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities